Brief: Eloxx Pharmaceuticals Announces Therapeutic Development Award From Cystic Fibrosis Foundation
29/03/2022 12:16
March 29 (Reuters) - Eloxx Pharmaceuticals Inc ELOX.O :
* ELOXX PHARMACEUTICALS ANNOUNCES THERAPEUTIC DEVELOPMENT
AWARD
FROM CYSTIC FIBROSIS FOUNDATION
* ELOXX PHARMACEUTICALS INC - CYSTIC FIBROSIS FOUNDATION (CF
FOUNDATION) TO PROVIDE AN AWARD OF UP TO $15.9 MILLION FOR
ONGOING ELX-02 CLINICAL PROGRAM
Source text for Eikon: ID:nGNX4l8QnJ
Further company coverage: ELOX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Eloxx Pharmaceuticals
See all newsNASDAQ RESUMED AT 02:24 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:19 PM
Brief: Eloxx Pharmaceuticals Provides ELX-02 And ZKN-013 Program Updates
Brief: Eloxx Pharmaceuticals Confirms That Alport Syndrome Patients Treated With Elx-02 In Phase 2 Study Had Improvement
Brief: Eloxx Pharmaceuticals Inc Reports Results In All Patients Treated With Elx-02 In Phase 2 Clinical Study For Alport Syndrome